{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:42:13Z","timestamp":1793029333956,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nucmedbio.2026.109664","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:49:14Z","timestamp":1786171754000},"page":"109664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical comparison of [111In]In-BPAMD and [99mTc]Tc-DPD for SPECT\/CT-based bone imaging"],"prefix":"10.1016","volume":"160-161","author":[{"given":"Veronika","family":"Felber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Mindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109664_bb0005","series-title":"Bone scanning in clinical practice","first-page":"31","article-title":"99mTc diphosphonate bone-scanning agents","author":"Fogelman","year":"1987"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2012.03.006","article-title":"Targeted radio-nuclide therapy of skeletal metastases","volume":"39","author":"Sartor","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2016.08.002","article-title":"Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases","volume":"91","author":"Lange","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ph10020045","article-title":"Novel radiolabeled bisphosphonates for PET diagnosis and endoradiotherapy of bone metastases","volume":"10","author":"Pfannkuchen","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0030","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1021\/ja054905u","article-title":"A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting","volume":"127","author":"Kub\u00ed\u010dek","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0035","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/la702753j","article-title":"Complexes of DOTA-bisphosphonate conjugates: probes for determination of adsorption capacity and affinity constants of hydroxyapatite","volume":"24","author":"Vitha","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0040","series-title":"Principles of bone biology","first-page":"1737","article-title":"Chapter 81 - bisphosphonates: mechanisms of action","author":"Roelofs","year":"2008"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0045","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.beem.2008.07.001","article-title":"Bisphosphonates: how do they work?","volume":"22","author":"Papapoulos","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/jm7012776","article-title":"Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy","volume":"51","author":"Vitha","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.nucmedbio.2012.04.007","article-title":"(68)Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter","volume":"39","author":"Fellner","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.nucmedbio.2013.04.012","article-title":"In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models","volume":"40","author":"Meckel","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10967-015-4225-z","article-title":"Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP","volume":"307","author":"Yousefnia","year":"2016","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0070","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s10967-014-3924-1","article-title":"Preparation and biological evaluation of 166Ho-BPAMD as a potential therapeutic bone-seeking agent","volume":"304","author":"Yousefnia","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s12149-015-1014-2","article-title":"Preparation, quality control and biodistribution assessment of (1)(5)(3)Sm-BPAMD as a novel agent for bone pain palliation therapy","volume":"29","author":"Rabie","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/ract-2015-2391","article-title":"Preparation and biodistribution assessment of 111In-BPAMD as a novel agent for bone SPECT imaging","volume":"103","author":"Yousefnia","year":"2015","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0085","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00259-009-1355-y","article-title":"PET\/CT imaging of osteoblastic bone metastases with 68Ga-bisphosphonates: first human study","volume":"37","author":"Fellner","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0090","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1039\/c0dt01504k","article-title":"Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS","volume":"40","author":"R\u00f6sch","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0959-8049(97)10128-9","article-title":"Bone metastases--The clinical problem","volume":"34","author":"Rubens","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0100","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00259-020-04867-y","article-title":"A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET\/CT, [68Ga]Ga-NODAGAZOL PET\/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases","volume":"48","author":"Lawal","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0110","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2967\/jnumed.117.200220","article-title":"Intraindividual comparison of 99mTc-methylene diphosphonate and prostate-specific membrane antigen ligand 99mTc-MIP-1427 in patients with osseous metastasized prostate cancer","volume":"59","author":"Rathke","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0115","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00259-018-4048-6","article-title":"Comparison of [68Ga]Ga-PSMA-11 PET\/CT with [18F]NaF PET\/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy","volume":"45","author":"Uprimny","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.semnuclmed.2023.07.004","article-title":"Bone metastasis in prostate cancer: bone scan versus PET imaging","volume":"54","author":"Mohseninia","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0125","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest Urol"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z","article-title":"Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID\/bg mice using LNCaP and lineage-derived metastatic sublines","volume":"77","author":"Wu","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pros.10199","article-title":"Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models","volume":"54","author":"Denmeade","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0140","series-title":"Bone scanning in clinical practice","first-page":"7","article-title":"99mTc diphosphonate uptake mechanism on bone","author":"Francis","year":"1987"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0145","series-title":"Radiopharmaceutical chemistry","author":"Lewis","year":"2019"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0150","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/ja00527a066","article-title":"Structural characterization of a technetium-99-diphosphonate complex. Implications for the chemistry of technetium-99m skeletal imaging agents","volume":"102","author":"Libson","year":"1980","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0165","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/cr900325h","article-title":"Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease","volume":"110","author":"Wadas","year":"2010","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.apradiso.2005.01.009","article-title":"On the \u201cartificial\u201d nature of Tc and the \u201ccarrier-free\u201d nature of 99mTc from 99Mo\/99mTc generators","volume":"63","author":"Alfassi","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0175","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0180","doi-asserted-by":"crossref","first-page":"15993","DOI":"10.1038\/s41598-022-20280-x","article-title":"Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT\/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2021.110037","article-title":"Unexpected transformation of n.c.a. [111In]InCl3 in stock solutions into an unreactive [111In]in-species","volume":"180","author":"Giammei","year":"2022","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0195","first-page":"2587","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0200","series-title":"Bone research protocols","first-page":"295","article-title":"Models of prostate cancer bone metastasis","author":"Park","year":"2019"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0205","first-page":"1","article-title":"Models of bone metastasis","volume":"67","author":"Campbell","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<246::AID-PROS5>3.0.CO;2-U","article-title":"Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment","volume":"39","author":"Koeneman","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.semnuclmed.2014.07.008","article-title":"Sodium 18F-fluoride PET\/CT of bone, joint, and other disorders","volume":"45","author":"Jadvar","year":"2015","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0225","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/bonekey.2016.4","article-title":"Mouse models for studying prostate cancer bone metastasis","volume":"5","author":"Dai","year":"2016","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0235","first-page":"214","article-title":"A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication","volume":"23","author":"Buell","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0240","first-page":"67","article-title":"Convenient formulation of 68Ga-BPAMD patient dose using lyophilized BPAMD kit and 68Ga sourced from different commercial generators for imaging of skeletal metastases","volume":"34","author":"Guleria","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0245","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.bmc.2008.02.062","article-title":"Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: comparison with 99mTc\u2013DPD complex","volume":"16","author":"Djoki\u0107","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0250","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2967\/jnumed.121.263371","article-title":"Synthesis and preclinical evaluation of 177Lu-labeled radiohybrid PSMA ligands for endoradiotherapy of prostate cancer","volume":"63","author":"Wurzer","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109664_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13550-015-0147-6","article-title":"(111In)PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery","volume":"5","author":"Schottelius","year":"2015","journal-title":"EJNMMI Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:26:39Z","timestamp":1793028399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0969805126000636"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109664","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical comparison of [111In]In-BPAMD and [99mTc]Tc-DPD for SPECT\/CT-based bone imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109664"}}